Want to see JP:3360 full AI Analyst Report?
Top Page
Ship Healthcare Holdings
(3360)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥2,558.00
▼(-1.01% Downside)
Action:Reiterated
Date:08/17/26
The score is driven primarily by stable financial performance (steady revenue growth, improving leverage, and positive free cash flow), partially offset by margin compression and softer 2026 profitability. Technical indicators are mixed and slightly soft versus key moving averages, while valuation is reasonable with a mid-range P/E and a supportive dividend yield.
Positive Factors
Steady multi-year revenue growth
The sustained revenue uptrend indicates durable demand and expanding business activity. Although growth has moderated recently, the multi-year increase provides a stable foundation for operations and supports continued scale across the company’s medical supplies activities.
Negative Factors
Persistent gross-margin compression
The multi-year decline in gross margin suggests ongoing pressure from product mix, procurement costs, pricing, or competition. If it continues, revenue growth may translate into limited profit expansion and could constrain the company’s ability to improve returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady multi-year revenue growth
The sustained revenue uptrend indicates durable demand and expanding business activity. Although growth has moderated recently, the multi-year increase provides a stable foundation for operations and supports continued scale across the company’s medical supplies activities.
Read all positive factors
Ship Healthcare Holdings (3360) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥207.09B
Dividend Yield2.56%
Average Volume (3M)255.53K
Price to Earnings (P/E)16.1
Beta (1Y)0.49
Revenue Growth6.54%
EPS Growth-2.44%
CountryJP
Employees7,819
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)145.61
Shares Outstanding94,350,136
10 Day Avg. Volume330,690
30 Day Avg. Volume255,526
Financial Highlights & Ratios
PEG Ratio-1.65
Price to Book (P/B)1.47
Price to Sales (P/S)0.31
P/FCF Ratio12.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)175.43
Revenue Forecast (FY)¥740.40B
Ship Healthcare Holdings Business Overview & Revenue Model
Company Description
Ship Healthcare Holdings, Inc. is an international enterprise engaged across the medical, healthcare, welfare, and nursing care domains. The company's diverse activities span four primary segments: Total Pack Produce, Medical Supply, Life Care, an...
How the Company Makes Money
null...
Ship Healthcare Holdings Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 731.21B | 718.16B | 678.23B | 630.99B | 572.28B | 514.35B |
| Gross Profit | 66.61B | 66.70B | 66.74B | 65.61B | 60.62B | 53.64B |
| EBITDA | 30.38B | 30.77B | 32.20B | 29.75B | 28.54B | 26.57B |
| Net Income | 13.45B | 13.39B | 15.13B | 13.80B | 12.06B | 12.17B |
Balance Sheet | ||||||
| Total Assets | 371.79B | 385.11B | 381.70B | 387.56B | 381.98B | 335.07B |
| Cash, Cash Equivalents and Short-Term Investments | 82.75B | 80.57B | 77.50B | 85.07B | 80.92B | 73.90B |
| Total Debt | 26.54B | 30.37B | 39.30B | 59.87B | 76.01B | 63.41B |
| Total Liabilities | 223.63B | 232.68B | 231.42B | 245.33B | 250.86B | 212.75B |
| Stockholders Equity | 146.83B | 151.07B | 149.08B | 139.53B | 128.04B | 118.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.76B | 16.56B | 28.42B | 10.64B | 9.30B |
| Operating Cash Flow | 0.00 | 22.04B | 20.38B | 31.61B | 14.11B | 12.43B |
| Investing Cash Flow | 0.00 | -2.08B | -4.03B | -7.20B | -6.77B | -3.87B |
| Financing Cash Flow | 0.00 | -16.33B | -24.62B | -20.48B | -1.02B | -8.84B |
Ship Healthcare Holdings Technical Analysis
Neutral
2584.00
Price Trends
2317.01
Positive
2284.60
Positive
2399.72
Negative
Market Momentum
7.97
Positive
50.62
Neutral
58.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Neutral. The current price of 2584 is above the 20-day moving average (MA) of 2416.78, above the 50-day MA of 2317.01, and above the 200-day MA of 2399.72, indicating a neutral trend. The MACD of 7.97 indicates Positive momentum. The RSI at 50.62 is Neutral, neither overbought nor oversold. The STOCH value of 58.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3360.
Ship Healthcare Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.80T | 22.96 | 9.19% | 1.39% | 14.05% | 31.94% | |
71 Outperform | ¥1.21T | 30.58 | 7.27% | 2.48% | 4.48% | -15.75% | |
69 Neutral | ¥2.35T | 30.18 | 8.94% | 1.65% | 7.80% | -27.73% | |
67 Neutral | ¥207.09B | 16.11 | 9.09% | 2.32% | 6.54% | -2.44% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | ¥256.47B | 17.81 | 5.37% | 2.03% | 2.68% | 144.20% |
* Healthcare Sector Average
JP:3360
Ship Healthcare Holdings
2,346.50
175.68
8.09%
JP:4543
Terumo
2,560.00
-68.05
-2.59%
JP:8086
Nipro
1,532.00
58.63
3.98%
JP:7733
Olympus
2,141.50
439.54
25.83%
JP:6869
Sysmex
1,920.00
72.10
3.90%
Ship Healthcare Holdings Corporate Events
Ship Healthcare Releases Q1 FY2026 Financial Results Briefing Materials
Aug 7, 2026
Ship Healthcare Holdings, Inc. released materials for its consolidated financial results briefing covering the three months ended June 30, 2026. The documents, prepared under strict internal design and formatting rules, outline the company’s...
Ship Healthcare lifts sales, holds forecasts and plans higher dividend
Aug 7, 2026
Ship Healthcare Holdings reported an 8% year-on-year rise in net sales to ¥176.4 billion for the quarter ended June 30, 2026, while operating profit slipped 5.7% to ¥2.8 billion and ordinary profit grew 9.2%. Profit attributable to owner...
Ship Healthcare Steps Up Share Buybacks Under Ongoing Capital Management Plan
Aug 5, 2026
Ship Healthcare Holdings has continued its share repurchase program, acquiring 513,400 common shares on the Tokyo Stock Exchange in July 2026 for a total of about 1.22 billion yen. These purchases are part of a board-approved plan to buy back up t...
Ship Healthcare Begins Share Buyback Under ¥5 Billion Authorization
Jul 2, 2026
Ship Healthcare Holdings has begun executing a share buyback program approved by its board on June 5, 2026, acquiring 368,300 common shares for 774,033,150 yen between June 8 and June 30 via market purchases on the Tokyo Stock Exchange. The buybac...
Ship Healthcare Launches ¥5 Billion Share Buyback to Boost Capital Efficiency
Jun 5, 2026
Ship Healthcare Holdings has approved a share buyback program as part of its medium-term capital policy, aiming to boost shareholder returns and enhance capital efficiency. The board authorized the repurchase of up to 3.3 million common shares, eq...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.